# Impact of Menstrual Cycle on Antiretroviral Pharmacokinetics in HIV-Infected Women

> **NCT01394133** · — · WITHDRAWN · sponsor: **University of Alabama at Birmingham**

## Conditions studied

- HIV Infected

## Interventions

- **DRUG:** Tenofovir, Emtricitabine, Atazanavir, Ritonavir

## Key facts

- **NCT ID:** NCT01394133
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2011-07
- **Primary completion:** 2013-04
- **Final completion:** 2013-04
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Lack of enrollment
- **Last updated:** 2013-04-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01394133

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01394133, "Impact of Menstrual Cycle on Antiretroviral Pharmacokinetics in HIV-Infected Women". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01394133. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*